OXADIAZOLE TRANSIENT RECEPTOR POTENTIAL CHANNEL INHIBITORS
The invention relates to methods of using compounds formula I:and pharmaceutically acceptable salts thereof wherein A, X, R1, R4 and n are as defined herein. In addition, the present invention relates to methods of manufacturing and methods of using the compounds of formula I as well as pharmaceutic...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | VILLEMURE, Elisia CHEN, Huifen LAROUCHE-GAUTHIER, Robin TERRETT, Jack Alexander BEAUMIER, Francis VOLGRAF, Matthew CONSTANTINEAU-FORGET, Lea GRAND-MAÎTRE, Chantal LÉPISSIER, Luce DÉRY, Martin STURINO, Claudio |
description | The invention relates to methods of using compounds formula I:and pharmaceutically acceptable salts thereof wherein A, X, R1, R4 and n are as defined herein. In addition, the present invention relates to methods of manufacturing and methods of using the compounds of formula I as well as pharmaceutical compositions containing such compounds. The compounds may be useful in treating diseases and conditions mediated by TRPA1, such as pain. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_SG11202009136RA</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>SG11202009136RA</sourcerecordid><originalsourceid>FETCH-epo_espacenet_SG11202009136RA3</originalsourceid><addsrcrecordid>eNrjZLDyj3B08XSM8vdxVQgJcvQL9nT1C1EIcnV2DQjxD1II8A8B8j0dfRScPRz9_Fx9FDz9PDydPIFywTwMrGmJOcWpvFCam0HFzTXE2UM3tSA_PrW4IDE5NS-1JD7Y3dDQyMDIwMDS0NgsyNGYSGUA4ckq3w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>OXADIAZOLE TRANSIENT RECEPTOR POTENTIAL CHANNEL INHIBITORS</title><source>esp@cenet</source><creator>VILLEMURE, Elisia ; CHEN, Huifen ; LAROUCHE-GAUTHIER, Robin ; TERRETT, Jack Alexander ; BEAUMIER, Francis ; VOLGRAF, Matthew ; CONSTANTINEAU-FORGET, Lea ; GRAND-MAÎTRE, Chantal ; LÉPISSIER, Luce ; DÉRY, Martin ; STURINO, Claudio</creator><creatorcontrib>VILLEMURE, Elisia ; CHEN, Huifen ; LAROUCHE-GAUTHIER, Robin ; TERRETT, Jack Alexander ; BEAUMIER, Francis ; VOLGRAF, Matthew ; CONSTANTINEAU-FORGET, Lea ; GRAND-MAÎTRE, Chantal ; LÉPISSIER, Luce ; DÉRY, Martin ; STURINO, Claudio</creatorcontrib><description>The invention relates to methods of using compounds formula I:and pharmaceutically acceptable salts thereof wherein A, X, R1, R4 and n are as defined herein. In addition, the present invention relates to methods of manufacturing and methods of using the compounds of formula I as well as pharmaceutical compositions containing such compounds. The compounds may be useful in treating diseases and conditions mediated by TRPA1, such as pain.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201029&DB=EPODOC&CC=SG&NR=11202009136RA$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201029&DB=EPODOC&CC=SG&NR=11202009136RA$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>VILLEMURE, Elisia</creatorcontrib><creatorcontrib>CHEN, Huifen</creatorcontrib><creatorcontrib>LAROUCHE-GAUTHIER, Robin</creatorcontrib><creatorcontrib>TERRETT, Jack Alexander</creatorcontrib><creatorcontrib>BEAUMIER, Francis</creatorcontrib><creatorcontrib>VOLGRAF, Matthew</creatorcontrib><creatorcontrib>CONSTANTINEAU-FORGET, Lea</creatorcontrib><creatorcontrib>GRAND-MAÎTRE, Chantal</creatorcontrib><creatorcontrib>LÉPISSIER, Luce</creatorcontrib><creatorcontrib>DÉRY, Martin</creatorcontrib><creatorcontrib>STURINO, Claudio</creatorcontrib><title>OXADIAZOLE TRANSIENT RECEPTOR POTENTIAL CHANNEL INHIBITORS</title><description>The invention relates to methods of using compounds formula I:and pharmaceutically acceptable salts thereof wherein A, X, R1, R4 and n are as defined herein. In addition, the present invention relates to methods of manufacturing and methods of using the compounds of formula I as well as pharmaceutical compositions containing such compounds. The compounds may be useful in treating diseases and conditions mediated by TRPA1, such as pain.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLDyj3B08XSM8vdxVQgJcvQL9nT1C1EIcnV2DQjxD1II8A8B8j0dfRScPRz9_Fx9FDz9PDydPIFywTwMrGmJOcWpvFCam0HFzTXE2UM3tSA_PrW4IDE5NS-1JD7Y3dDQyMDIwMDS0NgsyNGYSGUA4ckq3w</recordid><startdate>20201029</startdate><enddate>20201029</enddate><creator>VILLEMURE, Elisia</creator><creator>CHEN, Huifen</creator><creator>LAROUCHE-GAUTHIER, Robin</creator><creator>TERRETT, Jack Alexander</creator><creator>BEAUMIER, Francis</creator><creator>VOLGRAF, Matthew</creator><creator>CONSTANTINEAU-FORGET, Lea</creator><creator>GRAND-MAÎTRE, Chantal</creator><creator>LÉPISSIER, Luce</creator><creator>DÉRY, Martin</creator><creator>STURINO, Claudio</creator><scope>EVB</scope></search><sort><creationdate>20201029</creationdate><title>OXADIAZOLE TRANSIENT RECEPTOR POTENTIAL CHANNEL INHIBITORS</title><author>VILLEMURE, Elisia ; CHEN, Huifen ; LAROUCHE-GAUTHIER, Robin ; TERRETT, Jack Alexander ; BEAUMIER, Francis ; VOLGRAF, Matthew ; CONSTANTINEAU-FORGET, Lea ; GRAND-MAÎTRE, Chantal ; LÉPISSIER, Luce ; DÉRY, Martin ; STURINO, Claudio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_SG11202009136RA3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2020</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>VILLEMURE, Elisia</creatorcontrib><creatorcontrib>CHEN, Huifen</creatorcontrib><creatorcontrib>LAROUCHE-GAUTHIER, Robin</creatorcontrib><creatorcontrib>TERRETT, Jack Alexander</creatorcontrib><creatorcontrib>BEAUMIER, Francis</creatorcontrib><creatorcontrib>VOLGRAF, Matthew</creatorcontrib><creatorcontrib>CONSTANTINEAU-FORGET, Lea</creatorcontrib><creatorcontrib>GRAND-MAÎTRE, Chantal</creatorcontrib><creatorcontrib>LÉPISSIER, Luce</creatorcontrib><creatorcontrib>DÉRY, Martin</creatorcontrib><creatorcontrib>STURINO, Claudio</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>VILLEMURE, Elisia</au><au>CHEN, Huifen</au><au>LAROUCHE-GAUTHIER, Robin</au><au>TERRETT, Jack Alexander</au><au>BEAUMIER, Francis</au><au>VOLGRAF, Matthew</au><au>CONSTANTINEAU-FORGET, Lea</au><au>GRAND-MAÎTRE, Chantal</au><au>LÉPISSIER, Luce</au><au>DÉRY, Martin</au><au>STURINO, Claudio</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>OXADIAZOLE TRANSIENT RECEPTOR POTENTIAL CHANNEL INHIBITORS</title><date>2020-10-29</date><risdate>2020</risdate><abstract>The invention relates to methods of using compounds formula I:and pharmaceutically acceptable salts thereof wherein A, X, R1, R4 and n are as defined herein. In addition, the present invention relates to methods of manufacturing and methods of using the compounds of formula I as well as pharmaceutical compositions containing such compounds. The compounds may be useful in treating diseases and conditions mediated by TRPA1, such as pain.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_SG11202009136RA |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | OXADIAZOLE TRANSIENT RECEPTOR POTENTIAL CHANNEL INHIBITORS |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T01%3A51%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=VILLEMURE,%20Elisia&rft.date=2020-10-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ESG11202009136RA%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |